TTOO Rallies For 2nd Day, SAGE’s STATUS Flops, ICPT Warns Of Ocaliva Overdosing


The following are some of the biotech stocks that made their way onto the Day’s Gainers & Losers’ list of September 12, 2017.

GAINERS

1. Synlogic Inc. (SYBX)

Gained 22.63% to close Tuesday’s (Sep.12) trading at $17.50.

News: No news

Pipeline:

The Company’s lead product candidate is SYNB1020 for Hyperammonemia including Urea Cycle Disorder and Hepatic Encephalopathy. A healthy volunteer study with SYNB1020 was initiated in June 2017. Another investigational product in the pipeline is SYNB1618 for Phenylketonuria, and is under preclinical testing.

Recent event:

Synlogic completed its merger with Mirna Therapeutics to become NASDAQ listed company on August 28, 2017, and commence trading on the NASDAQ Capital Market under the ticker symbol “SYBX” that day.

2. MannKind Corp. (MNKD)

Gained 9.31% to close Tuesday’s trading at $2.23.

News: No news

Recent events:

— On August 7, 2017, the Company…



Article Source…

Leave a Reply

Your email address will not be published. Required fields are marked *